| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | Dec 10, 2024 | AN2 Therapeutics, Inc. | Director | Buy | 82.5 | +60,000 | 1.67% | ✗ | $86.7K |
| Nov 26, 2024 | Nov 27, 2024 | AN2 Therapeutics, Inc. | Director | Buy | 87.5 | +75,000 | 3.37% | ✗ | $105.7K |
| Nov 19, 2024 | Nov 21, 2024 | AN2 Therapeutics, Inc. | Director | Buy | 95.0 | +200,000 | 10.26% | ✗ | $213.1K |
| Jan 12, 2024 | Jan 17, 2024 | AN2 Therapeutics, Inc. | Director | Sell | 53.8 | -1,425 | -0.16% | ✓ | $31.2K |
| Jan 10, 2024 | Jan 12, 2024 | AN2 Therapeutics, Inc. | Director | Sell | 48.8 | -3,669 | -0.41% | ✓ | $80.4K |
| Mar 29, 2022 | Mar 31, 2022 | AN2 Therapeutics, Inc. | Director | Buy | 100.0 | +153,334 | 20.40% | ✗ | $2.3M |